Capacity Bio is a therapeutics company that is focused on mitophagy.
Capacity Bio has raised $35.0M in total funding. The most recent round was Series A. The last funding was announced in March 2023.
Capacity Bio's investors include Insight Partners, RA Capital Management, Remiges Ventures.
Capacity Bio is headquartered in Palo Alto, United States.
Capacity Bio is a therapeutics company that is focused on mitophagy.
Capacity Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Capacity Bio — Funding & Investors." VCBacked, March 31, 2023, https://www.vcbacked.co/company/capacity-bio. Accessed July 20, 2026.
VCBacked. (2023). Capacity Bio — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/capacity-bio
{{cite web |title=Capacity Bio — Funding & Investors |url=https://www.vcbacked.co/company/capacity-bio |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated